Department of Medicine

May 4 symposium to highlight heart-related basic, clinical research

The Division of Cardiovascular Medicine will host the Vanderbilt Cardiovascular Symposium 2016 on May 4, highlighting ongoing vascular and heart-related basic and clinical research.

First subject enrolled in international HIV prevention study

This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.

Switching breast cancer off

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.

Immune defenses in asthma

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

DNA sequence visualization

VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

Vanderbilt Asthma, Sinus, Allergy Program sees uptick in alpha-gal syndrome

Vanderbilt’s Asthma, Sinus, and Allergy Program has seen an increase in the number of patients being treated for alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.

1 84 85 86 87 88 113